Ascensia Diabetes Care
About Ascensia Diabetes Care
Established in 2016 through the acquisition of Bayer Diabetes Care by Panasonic Healthcare Holdings, Ascensia Diabetes Care is a global company dedicated to improving the health and lives of people with diabetes. Already including the world-renowned CONTOUR™ range of blood glucose monitoring systems, we are committed to adding more innovative and life-changing products to our portfolio.YEAR FOUNDED:
2016
LEADERSHIP:
CEO: Michael Kloss
CMO: David Simmons
CIO: Peter Eckenberg
CFO: Jan Vannerum
PRODUCTS:
All Products
FOLLOW ASCENSIA:
Tweets by Ascensia
36 articles about Ascensia Diabetes Care
-
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System - February 12, 2024
2/12/2024
Ascensia Diabetes Care today announced that Medicare has significantly expanded access to the Eversense E3 CGM System, the longest lasting CGM available, with the implementation of Local Coverage Determinations providing access to implantable CGM for basal only patients, by the first three Medicare Administrative Contractors (MACs).
-
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
2/12/2024
Ascensia Diabetes Care announced that Medicare has significantly expanded access to the Eversense E3 CGM System, the longest lasting CGM available, with the implementation of Local Coverage Determinations providing access to implantable CGM for basal only patients, by the first three Medicare Administrative Contractors.
-
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
2/6/2024
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care.
-
Ascensia Diabetes Care and Senseonics Announce 'The CGM for Real Life' Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes
10/9/2023
Ascensia Diabetes Care and Senseonics Holdings, Inc. have launched a new U.S. advertising and marketing campaign for Eversense® E3 CGM System.
-
Ascensia Diabetes Care Expands Payment Assistance and Simple Savings Program for Eversense E3 CGM System
5/9/2023
Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring System portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring Systems, announces that it has significantly expanded Eversense PASS, a Payment Assistance and Simple Savings program designed to enhance affordability and access to the Eversense E3 CGM System.
-
ASCENSIA DIABETES CARE MARKS ONE-YEAR ANNIVERSARY OF US EVERSENSE E3 CGM LAUNCH WITH COMMERCIAL UPDATE AND INNOVATION OUTLOOK
4/24/2023
Ascensia Diabetes Care , a global diabetes care company, maker of the CONTOUR ® Blood Glucose Monitoring (BGM) system portfolio and exclusive distributor of Eversense ® Continuous Glucose Monitoring (CGM) Systems, marks the one-year anniversary of launching Eversense ® E3 in the U.S. with a commercial update and outlook on future innovation.
-
Ascensia Diabetes Care Collaborates With SNAQ to Support Mealtime Decision-Making for People With Diabetes
2/21/2023
Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring system portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring Systems, announces a landmark global collaboration with SNAQ, an award-winning app-based solution that offers key insights on food and nutrition for people with diabetes.
-
Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM)
11/3/2022
Senseonics Holdings, Inc. and Ascensia Diabetes Care announced the launch of a collaboration with the Nurse Practitioner Group, a leader in multidisciplinary health services and medical staffing solutions.
-
Ascensia Diabetes Care Completes Initial European Launch of the Next-Generation Eversense E3 Contuinous Glucose Monitoring System
10/10/2022
Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® blood glucose monitoring system portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring Systems, announces that it has successfully completed the initial European launch of the next-generation Eversense® E3 CGM System.
-
Ascensia Diabetes Care Relaunches Successful 'This is Diabetes' Competition in Support of IDF's World Diabetes Day
9/27/2022
Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® blood glucose monitoring system portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring Systems, announces that it has relaunched its successful 'This is Diabetes' art and photo competition in support of World Diabetes Day 2022.
-
Ascensia Diabetes Care Announces European Approval of the Next-Generation Eversense E3 Continuous Glucose Monitoring System
6/16/2022
Ascensia Diabetes Care, a global diabetes care company, maker of CONTOUR® blood glucose monitoring system portfolio and distributor of Eversense® Continuous Glucose Monitoring Systems, announces that its partner Senseonics Holdings, Inc. has received CE Mark approval for the Eversense® E3 Continuous Glucose Monitoring System, clearing the way for its use in European Union member countries.
-
Senseonics has finally received approval from the U.S. Food and Drug Administration for its Eversense E3 Continuous Glucose Monitoring System (CGM) System.
-
ASCENSIA DIABETES CARE ANNOUNCES FDA APPROVAL OF THE EVERSENSE E3 CONTINUOUS GLUCOSE MONITORING SYSTEM FOR USE FOR UP TO 6 MONTHS
2/14/2022
Ascensia Diabetes Care has received approval from the U.S. Food and Drug Administration (FDA) for the next-generation Eversense ® E3 Continuous Glucose Monitoring (CGM) System.
-
Ascensia Diabetes Care Honored At Joslin Diabetes Center High Hopes "Virtual" Gala
11/15/2021
Ascensia Diabetes Care, a global diabetes care company, makers of CONTOUR® blood glucose monitoring system portfolio and distributors of the Eversense® continuous glucose monitoring system, was named as an honoree at the Joslin Diabetes Center High Hopes Gala, to celebrate the 100th Anniversary of Insulin, held on November 13th.
-
Senseonics Announces a Collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, Ohio
9/13/2021
Senseonics Holdings, Inc. and Ascensia Diabetes Care have announced that the University Hospitals Accountable Care Organization in Cleveland, Ohio has begun offering the Eversense® CGM System to its Medicare enrollees effective early September, 2021.
-
Ascensia Diabetes Care And Its Employees Excited To Support Spare A Rose Campaign For The Fourth Consecutive Year
2/11/2021
Ascensia Diabetes Care, a leading global diabetes care company and the maker of the CONTOUR® range of blood glucose monitoring systems, has once again decided to support the Spare A Rose campaign, organized by Life for a Child, for the fourth consecutive year.
-
Ascensia Diabetes Care chooses VisiQuate HealthMobile.D data platform solution to accelerate their data strategy
9/22/2020
Complex data integration and advanced visualizations will bring new benefits to patients, physicians, health plans, and more [22-September-2020] SANTA ROSA, Calif. , Sept. 22, 2020 /PRNewswire/ -- To manage a complex condition like diabetes, it's critical to get everyone in the entire circle of care on the same page: patients, their friends and families, physicians, d
-
Senseonics Announces Strategic Collaboration with Ascensia Diabetes Care
8/10/2020
Senseonics Holdings, Inc. announced the formation of a strategic partnership with Ascensia Diabetes Care, through a commercialization and collaboration agreement, which will make Ascensia the exclusive worldwide distributor of Senseonics’ Eversense® CGM systems.
-
PHC Holdings Corporation and Ascensia Diabetes Care Announce Financing Agreement and Exclusive Global Commercial Agreement With Senseonics
8/10/2020
PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, announced a strategic partnership with Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring systems for people with diabetes.
-
Ascensia Continues to Proudly Support Life for a Child's Spare a Rose Fundraising Campaign in 2020
2/14/2020
Ascensia Diabetes Care, a leading global diabetes care company, announced that they will be continuing their support for this years' Spare a Rose campaign.